一文总结,糖尿病易诱发的12种并发症!

健康   2024-11-23 19:59   北京  

点击蓝字 / 关注我们

作者:朱益丽、于一江

单位:淮安市中医院(淮安市糖尿病医院)

来源:医学界内分泌频道


糖尿病作为一种慢性代谢性疾病,通常不会在患者身上独立存在,而常与其他诸多非健康状态或疾病并存,在这个“数病齐发”的过程中糖尿病往往扮演着“助攻手”的角色,今天就让我们展开一次大盘点,细数糖尿病都会给我们带来怎样的疾病风险……

 


眼疾


糖尿病是白内障的危险因素[1],年龄与白内障密切相关,在老年人中白内障是最主要的致盲原因[2]



糖尿病患者的青光眼风险较非糖尿病更高[3]


干眼症是最常见的眼部疾病[4],糖尿病与干眼症的风险显著相关[5]




口腔疾病


糖尿病患者口腔疾病的患病率、病程和严重程度均较非糖尿病人群明显增加[6]。牙周炎是糖尿病的常见伴发疾病之一,糖尿病是牙周炎的重要危险因素,糖尿病患者与非糖尿病人群相比,牙周炎的发生风险增加近3倍。

 


肾病


糖尿病肾脏病变是我国慢性肾脏病的主要原因[7]




神经病变


糖尿病神经病变是糖尿病常见的慢性并发症之一,是一组具有多种临床表现的异质性疾病,病变可累及中枢神经和周围神经。

远端对称性多发性神经病变:是最常见的糖尿病周围神经病变,约占糖尿病神经病变的 75%,是糖尿病足溃疡的重要危险因素,也是跌倒及骨折的重要原因[8]

 


骨折


糖尿病患者的骨折风险明显超过非糖尿病人群[9]

 




精神疾病


老年糖尿病患者发生抑郁的风险高于非糖尿病的老年人[10]

 


肿瘤


糖尿病患者肿瘤风险增加,包括肝细胞癌、肝胆管癌、胰腺癌、乳腺癌、卵巢癌、子宫内膜癌和胃肠道恶性肿瘤等多种癌症[11]

 


心脑血管疾病


心血管疾病:糖尿病病人比正常人更容易产生动脉粥样硬化,而且发展迅速,从而导致冠心病、脑血管意外等。在T1DM患者中冠心病(CHD)、心肌梗死、心力衰竭、房颤的患病率明显升高[12]


心脏自主神经病变:血糖变异性大的糖尿病患者更有可能出现心脏自主神经病变[13]



脑血管疾病:糖尿病是中风最重要的危险因素之一。单独患有2型糖尿病(T2DM)会使中风的风险增加1.5到4倍;T2DM和较高的HbA1c水平与任何缺血性中风,大动脉中风和小血管中风的风险较高相关[14]


糖尿病患者下肢动脉病变通常是指下肢动脉粥样硬化性病变(lower extremity atherosclerotic disease,LEAD)。中国DIALEAD研究显示,我国50岁以上T2DM中LEAD的总患病率为21.2%,且患病率随着年龄、糖尿病病程增加而升高[15]。在患LEAD的T2DM患者中,心肌梗死、脑卒中、冠心病导致的死亡风险均增加[16]

 


感染


糖尿病足是指糖尿病患者因下肢远端神经病变和血管病变导致的足部感染、溃疡,甚至深层组织破坏,是糖尿病严重的慢性并发症之一,严重者可以导致截肢和死亡。我国糖尿病足患者的总截肢率为19.03%[17]


感染:糖尿病与多种感染的风险增加有关,包括:皮肤和软组织感染、呼吸道感染、泌尿生殖道感染、血液感染、头颈部感染、胃肠道感染、骨感染等[18]

  


肝胆疾病


肝脏疾病:与非糖尿病患者相比,糖尿病患者肝脂肪变性的概率更高,与其内脏脂肪组织(VAT)面积相关[19];此外,非酒精性脂肪肝病(NAFLD)可以进展为晚期纤维化,尤其是在2型糖尿病患者中[20]


胆囊结石:与没有糖尿病的患者相比,患有2型糖尿病的患者发生胆囊结石的风险增加[21]

  

十一


血液疾病


贫血:贫血是糖尿病成年患者中的中度公共卫生问题,性别、糖尿病持续时间、糖尿病并发症的存在和糖尿病合并症被确定为与贫血相关的因素。其中,贫血的发生在女性比男性糖尿病患者更多;糖尿病≥5年的患者比糖尿病病程为1-5年的患者更容易发生贫血;有合并症的糖尿病患者比没有合并症的糖尿病患者更容易贫血[22]

  

十二


其他


甲状腺疾病:糖尿病患者的甲状腺疾病患病率是非糖尿病患者的2-3倍[23];特别是自身免疫性甲状腺炎[24]

 


电解质紊乱:糖尿病患者发生酮症酸中毒时,出现严重电解质紊乱,其血清钾、钠、磷、镁含量和有效渗透压明显升高[25]

 

痴呆:2型糖尿病轻度认知障碍患者较非糖尿病患者更易转化为痴呆,2型糖尿病是轻度认知障碍患者痴呆转化的独立危险因素[26]

 

还有很多疾病都因糖尿病而导致患病率上升,或者因糖尿病而加重。所以我们在临床工作中必须注意糖尿病的防治。

  

参考文献:

[1]Drinkwater JJ, Davis WA, Davis T. A systematic review of risk factors for cataract in type 2 diabetes[J]. Diabetes Metab Res Rev, 2019, 35(1): e3073. DOI: 10.1002/dmrr.3073.

[2]GBD 2019 Blindness and Vision Impairment Collaborators, Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study[J]. Lancet Glob Health, 2020, S2214109X(20)304897. DOI: 10.1016/S2214109X(20)304897.

[3]Song BJ, Aiello LP, Pasquale LR. Presence and risk factors for glaucoma in patients with diabetes[J]. Curr Diab Rep, 2016, 16(12):124.

[4]Song P, Xia W, Wang M, et al. Variations of dry eye disease prevalence by age, sex and geographic characteristics in China: a systematic review and metaanalysis[J]. J Glob Health, 2018, 8(2):020503. DOI: 10.7189/jogh.08.020503.

[5]Yoo TK, Oh E. Diabetes mellitus is associated with dry eye syndrome: a metaanalysis[J]. Int Ophthalmol, 2019, 39(11):26112620. DOI: 10.1007/s1079201901110y

[6]Wu CZ, Yuan YH, Liu HH, et al. Epidemiologic relationship between periodontitis and type 2 diabetes mellitus[J]. BMC Oral Health, 2020, 20(1): 204. DOI: 10.1186/ s1290302001180w.

[7]Zhang L, Long J, Jiang W, et al. Trends in chronic kidney disease in China[J]. N Engl J Med, 2016, 375(9):905906. DOI: 10.1056/NEJMc1602469.

[8]PopBusui R, Boulton AJ, Feldman EL, et al. Diabetic neuropathy: a position statement by the American Diabetes Association[J]. Diabetes Care, 2017, 40(1): 136154. DOI:10.2337/dc162042.

[9]Gilbert MP, Pratley RE. The impact of diabetes and diabetes medications on bone health[J]. Endocr Rev, 2015, 36(2):194213. DOI: 10.1210/er.20121042.

[10]Maraldi C, Volpato S, Penninx BW, et al. Diabetes mellitus, glycemic control, and incident depressive symptoms among 70to 79yearold persons: the health, aging, and body composition study[J]. Arch Intern Med, 2007, 167(11):11371144.

[11] Sacerdote C, Ricceri F. Epidemiological dimensions of the association between type 2 diabetes and cancer: a review of observational studies[J]. Diabetes Res Clin Pract, 2018, 143:369377. DOI: 10.1016/j.diabres.2018.03.002.

[12]Xingming Cai, Jiayong Li, Wenting Cai, et al.Meta-analysis of type 1 diabetes mellitus and risk of cardiovascular disease. Journal of Diabetes and its Complications. 2021, 45(4),107833.

[13]Nyiraty S, Pesei F, Orosz A, et al. Cardiovascular autonomic neuropathy and glucose ariability in patients with type 1 diabetes: is there an association? [J]. Front Endocrinol (Lausanne), 2018, 9: 174. DOI: 10.3389/ fendo.2018.00174.

[14]Marios K Georgakis, Eric L Harshfield, et al. Diabetes Mellitus, Glycemic Traits, and Cerebrovascular Disease: A Mendelian Randomization Study.Neurology. 2021,96(13): e1732- e1742.

[15] Zhang X, Ran X, Xu Z, et al. Epidemiological characteristics of lower extremity arterial disease in Chinese diabetes patients at high risk: a prospective, multicenter, crosssectional study[J]. J Diabetes Complications, 2018, 32(2):150156. DOI: 10.1016/j.jdiacomp.2017.10.003.

[16] Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease[J]. N Engl J Med, 1992, 326(6):381386.

[17] Jiang Y, Ran X, Jia L, et al. Epidemiology of type 2 diabetic foot problems and predictive factors for amputation in China[J]. Int J Low Extrem Wounds, 2015, 14(1): 1927. DOI: 10.1177/1534734614564867.

[18]Abu-Ashour W, Twells L, Valcour J, et al. The association between diabetes mellitus and incident infections: a systematic review and meta-analysis of observational studies. BMJ Open Diabetes Res Care. 2017,5:e000336.

[19]Sohrab Nobarani, Fariba Alaei-Shahmiri, Rokhsareh Aghili, et al. Visceral Adipose Tissue and Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes.Dig Dis Sci. 2021 Mar 31. doi: 10.1007/s10620-021-06953-z.

[20]Nabil Noureddin, Mazen Noureddin, Amandeep Singh, Naim Alkhouri.Progression of Nonalcoholic Fatty Liver Disease-Associated Fibrosis in a Large Cohort of Patients with Type 2 Diabetes.Dig Dis Sci. 2021 Mar 29. doi: 10.1007/s10620-021-06955-x.

[21]Chien-Hua Che,Cheng-Li Lin, Chung-Y. Hsu, Chia-Hung Kao. Association Between Type I and II Diabetes With Gallbladder Stone Disease.Front Endocrinol (Lausanne). 2018; 9: 720.

[22]Teshome Tujuba, Behailu Hawulte Ayele, Sagni Girma Fage, Fitsum Weldegebreal .Anemia among Adult Diabetic Patients Attending a General Hospital in Eastern Ethiopia: a Cross-sectional Study.Diabetes Metab Syndr Obes. 2021;14:467-476. doi: 10.2147/DMSO.S289298.

[23]K Vondra, J Vrbikova, K Dvorakova.Thyroid gland diseases in adult patients with diabetes mellitus.Minerva Endocrinol. 2005 Dec;30(4):217-36.

[24]Z Schroner, I Lazurova, J Petrovicova.Autoimmune thyroid diseases in patients with diabetes mellitus.Bratisl Lek Listy. 2008;109(3):125-9.

[25]Dongyun Su, Jing Li, Manli Guo, et al. Clinical Analysis of Electrolyte Disorders in Patients with Diabetic Ketoacidosis.Clin Lab. 2021 Jan 1;67(1). doi: 10.7754/Clin.Lab.2020.200309.

[26]Andreea Ciudin,Ana Espinosa, et al.Type 2 diabetes is an independent risk factor for dementia conversion in patients with mild cognitive impairment.J Diabetes Complications. 2017 Aug;31(8):1272-1274.

欢迎投稿

小编微信:druglive,vipnote

稿件要求:临床用药相关的专业文章

稿件格式:word文档

收听药评中心,每天都能进步一点点!

药评中心
药评中心,药师的家园,医生的朋友,最给力的用药助手,助您迅速提升工作技能。小编:vipnote,商务合作请加:druglive
 最新文章